Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 15d PGA2 cPLA2i 1.0 BCD110605C16 1.58 pmol/ml of medium
- 15d PGA2 cPLA2i 1.0 BCD110605C18 0.772 pmol/ml of medium
- 15d PGA2 cPLA2i 1.0 BCD110605C17 1.39 pmol/ml of medium
- 15d PGA2 cPLA2i 4.0 BCD110605C34 1.39 pmol/ml of medium
- 15d PGA2 cPLA2i 4.0 BCD110605C36 0.897 pmol/ml of medium
- 15d PGA2 cPLA2i 4.0 BCD110605C35 1.79 pmol/ml of medium
- 15d PGA2 cPLA2i 20.0 BCD110605C53 1.25 pmol/ml of medium
- 15d PGA2 cPLA2i 20.0 BCD110605C54 0.74 pmol/ml of medium
- 15d PGA2 cPLA2i 20.0 BCD110605C52 0.589 pmol/ml of medium
- 15d PGA2 PLDi 1.0 BCD110605C10 0.728 pmol/ml of medium
- 15d PGA2 PLDi 1.0 BCD110605C12 2.62 pmol/ml of medium
- 15d PGA2 PLDi 1.0 BCD110605C11 1.99 pmol/ml of medium
- 15d PGA2 PLDi 4.0 BCD110605C30 1.61 pmol/ml of medium
- 15d PGA2 PLDi 4.0 BCD110605C29 0.813 pmol/ml of medium
- 15d PGA2 PLDi 4.0 BCD110605C28 1.15 pmol/ml of medium
- 15d PGA2 PLDi 20.0 BCD110605C48 1.97 pmol/ml of medium
- 15d PGA2 PLDi 20.0 BCD110605C47 1.26 pmol/ml of medium
- 15d PGA2 PLDi 20.0 BCD110605C46 0.975 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 1.0 BCD110605C19 0.885 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 1.0 BCD110605C21 1.37 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 1.0 BCD110605C20 1.2 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 4.0 BCD110605C39 1.56 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 4.0 BCD110605C37 1.47 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 4.0 BCD110605C38 2.3 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 20.0 BCD110605C55 10.6 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 20.0 BCD110605C57 11.3 pmol/ml of medium
- 15d PGA2 KDO+cPLA2i 20.0 BCD110605C56 12.3 pmol/ml of medium
- 15d PGA2 KDO+PLDi 1.0 BCD110605C15 1.59 pmol/ml of medium
- 15d PGA2 KDO+PLDi 1.0 BCD110605C14 1.5 pmol/ml of medium
- 15d PGA2 KDO+PLDi 1.0 BCD110605C13 1.01 pmol/ml of medium
- 15d PGA2 KDO+PLDi 4.0 BCD110605C32 5.28 pmol/ml of medium
- 15d PGA2 KDO+PLDi 4.0 BCD110605C31 4.07 pmol/ml of medium
- 15d PGA2 KDO+PLDi 4.0 BCD110605C33 3.6 pmol/ml of medium
- 15d PGA2 KDO+PLDi 20.0 BCD110605C49 22.8 pmol/ml of medium
- 15d PGA2 KDO+PLDi 20.0 BCD110605C51 23.4 pmol/ml of medium
- 15d PGA2 KDO+PLDi 20.0 BCD110605C50 21.4 pmol/ml of medium
- 15d PGA2 KDO + ATP 1.0 BCD110605C07 1.13 pmol/ml of medium
- 15d PGA2 KDO + ATP 1.0 BCD110605C09 1.33 pmol/ml of medium
- 15d PGA2 KDO + ATP 1.0 BCD110605C08 1.21 pmol/ml of medium
- 15d PGA2 KDO + ATP 4.0 BCD110605C25 5.53 pmol/ml of medium
- 15d PGA2 KDO + ATP 4.0 BCD110605C26 5.26 pmol/ml of medium
- 15d PGA2 KDO + ATP 4.0 BCD110605C27 3.67 pmol/ml of medium
- 15d PGA2 KDO + ATP 20.0 BCD110605C45 27.4 pmol/ml of medium
- 15d PGA2 KDO + ATP 20.0 BCD110605C43 19.8 pmol/ml of medium
- 15d PGA2 KDO + ATP 20.0 BCD110605C44 23.9 pmol/ml of medium
- 15d PGA2 C 0.0 BCD110605C02 1.26 pmol/ml of medium
- 15d PGA2 C 0.0 BCD110605C01 4.02 pmol/ml of medium
- 15d PGA2 C 0.0 BCD110605C03 1.44 pmol/ml of medium
- 15d PGA2 C 1.0 BCD110605C06 1.93 pmol/ml of medium
- 15d PGA2 C 1.0 BCD110605C05 1.31 pmol/ml of medium